Update: SHWZ - Analyst Coverage and Latest CEO Interview Update: Schwazze (Ticker: SHWZ)
Benchmark on December 15th, 2021 initiated coverage of SHWZ at $4/share
https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Benchmark+Starts+Medicine+Man+Technologies+%28SHWZ%29+at+Buy/19346257.html
This is in line with Noble Capital Market's 12-month Target Share price of $4/share as well.
Below is the latest interview by Crux Investors with CEO Justin Dye.
https://www.youtube.com/watch?v=qeTFy3c3KWI
Happy Holidays and Happy Investing